Giulia Troshina

Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals

Ana Lleò, Andrea Aglitti, Alessio Aghemo et al. · Digestive and Liver Disease · 2018 · 63 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology

Gian Paolo Caviglia, Michela Ciruolo, Maria Lorena Abate et al. · Cancers · 2020 · 42 citations · Full text

Medicine, Oncology, Pathology +17

Inosine Triphosphatase Polymorphisms and Ribavirin Pharmacokinetics as Determinants of Ribavirin-Associate Anemia in Patients Receiving Standard Anti-HCV Treatment

Antonio D’Avolio, Alessia Ciancio, Marco Siccardi et al. · Therapeutic Drug Monitoring · 2012 · 39 citations · Full text

Medicine, Hematology, Pharmacology +14

Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

Aimilia Karampatou, Xue Han, Loreta A. Kondili et al. · Journal of Hepatology · 2017 · 36 citations · Full text

Medicine, Gynecology, Obstetrics +16

Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment

Antonio D’Avolio, Alessia Ciancio, Marco Siccardi et al. · Therapeutic Drug Monitoring · 2012 · 33 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Infectious Diseases +16